SEARCH RESULTS FOR: "Tag: NKTR"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2020(2)
2019(4)
2018(9)
2017(3)
2015(1)
CATEGORIES
Analyst Update(2)
Best and Worst Stocks(2)
Buzz Stocks(6)
Earnings Preview(1)
Editor's Pick(3)
General(1)
Intraday Option Activity(1)
Midday Market Check(2)
Quantitative Analysis(3)
Stocks On the Move(2)
Technical Analysis(3)

1/23/2020 11:43 AM
Biopharmaceutical stock Nektar Therapeutics (NASDAQ:NKTR) is down 0.5% this afternoon, last seen at $22.02. NKTR has recently struggled to gain momentum, but earlier this month touched its highest in...
1/10/2020 1:34 PM
The shares of Nektar Therapeutics (NASDAQ:NKTR) are pacing for their biggest one-day jump in almost two years after the firm amended its collaboration agreement with Bristol-Myers Squibb (BMY). The t...
9/27/2019 9:35 AM
It was announced last night that casino name Las Vegas Sands Corp. (NYSE:LVS) will be joining the S&P 500 Index (SPX), replacing Nektar Therapeutics (NKTR), which is headed to the S&P MidCap 400 Inde...
8/9/2019 10:04 AM
Nektar Therapeutics (NASDAQ:NKTR) stock opened at its lowest level since mid-2017 today -- down 36% at $18.01 -- after the drugmaker unveiled manufacturing issues with bempeg, its experimental cancer ...
8/1/2019 12:19 PM
A big winner out of the healthcare sector today is Nektar Therapeutics (NASDAQ:NKTR), after the Food and Drug Administration (FDA) granted "breakthrough" therapy status to the company's lead cancer dr...